Sale of UK's Vaccine Manufacturing and Innovation Centre

BMJ. 2022 Feb 23:376:e069999. doi: 10.1136/bmj-2022-069999.

Authors

Rebecca E Glover¹, Adam P Roberts², Andrew C Singer³, Claas Kirchhelle^{4

5}

Affiliations

¹ Antimicrobial Resistance Centre, London School of Hygiene and Tropical Medicine, London, UK rebecca.glover@lshtm.ac.uk.
² Liverpool School of Tropical Medicine, Liverpool, UK.
³ UK Centre for Ecology and Hydrology, Wallingford, UK.
⁴ University College Dublin, Dublin, Ireland.
⁵ Oxford Martin Schoool, Oxford, UK.

PMID: 35197301
DOI: 10.1136/bmj-2022-069999

No abstract available

Publication types

Editorial

MeSH terms

COVID-19 / prevention & control
COVID-19 Vaccines / economics*
Commerce / economics*
Humans
Pandemics
SARS-CoV-2
United Kingdom

Substances

COVID-19 Vaccines